Lasers to Treat Gum Disease

Lasers to Treat Gum Disease

In 2004, the US. Food and Drug Administration approved the LANAP (Laser Assisted New Attachment Procedure) for the treatment of periodontitis or gum disease.  In LANAP periodontal surgery, a dental laser is used to treat the periodontal pocket.  The laser energy selectively removes diseased or infected pocket epithelium from the underlying connective tissue.  Since the laser energy is quite selective for pocket epithelium, it allows for healing and regeneration of the tissues.  After the LANAP procedure, most patients experience new root surface coating (cementum) and new connective tissues (periodontal ligament) formation (collagen) on tooth roots, preventing tooth loss.  Pocket depth reduction is comparable to that achieved by conventional respective surgery.  Significant post-operative reduction in gingival inflammation and bleeding on probing are the desirable results seen with the LANAP protocol.  Minimal pain is easily controlled with the use of over the counter NSAIDs such as ibuprofen.  With normal three-month periodontal recall and maintenance, the LANAP-provided new attachment is stable and has proven resistant to future periodontal breakdown.

New Reports Confirm Perio-Systemic Connection and Outline Clinical Recommendations

New Reports Confirm Perio-Systemic Connection and Outline Clinical Recommendations

The American Academy of Periodontology (AAP), in collaboration with the European Federation of Periodontology (EFP), recently published a series of consensus reports that analyze the scientific evidence linking periodontal disease to other systemic diseases, including diabetes, cardiovascular disease and adverse pregnancy outcomes.  There is strong evidence that periodontitis provides an increased risk for future cardiovascular disease.  Periodontal treatment may provide beneficial effects on diabetes outcomes and should be part of ongoing diabetes management.  The complete consensus reports are freely available online (http://www.joponline.org/toc/jop/84/4-s).

New Research Supports Assessing Risk, Preventive Treatment for Periodontal Disease

New Research Supports Assessing Risk, Preventive Treatment for Periodontal Disease

The American Academy of Periodontology (AAP) supports new research(http://jdr.sagepub.com/content/early/2013/06/05/0022034513492336.full) published online in the Journal of Dental Research confirming the need for careful risk assessment to determine which patients may benefit from additional treatment to prevent periodontal disease.  Periodontal disease impacts over half of the U.S. adult population, according to the Centers for Disease Control and Prevention (CDC).  The AAP recommends that all patients receive a comprehensive periodontal evaluation once a year to effectively screen and assess risk for disease, and to guide preventive care.

Half of American Adults Suffer From Gum Disease

Half of American Adults Suffer From Gum Disease

One out of every two American adults aged 30 and over has periodontal disease, according to recent findings from the Center for Disease Control and Prevention (CDC).  A study titled Prevalence of Periodontitis in Adults in the United States: 2009 and 2010 estimates that 47.2 percent, or 64.7 million American adults, have mild, moderate or severe periodontitis, the more advanced form of periodontal disease.  In adults 65 and older, prevalence rates increase to 70.1 percent.  This study is published in the Journal of Dental Research, the official publication of the International and American Associations for Dental Research

© Copyright 2017 Dental Implant & Periodontal Partners, LLP
Privacy Policy (pdf)   |   Accessibility Policy

5932 W. Parker Road #700 | Plano, TX 75093 | (972) 612-2040